European shares declined as rising crude oil prices fueled inflation fears, while Novartis stock tumbled following two failed late-stage drug trials. Meanwhile, Sandoz gained ground on ambitious sales
reuters · 2026-09-08 00:13
Sandoz filed an anti-dumping complaint with the EU Commission against Chinese amoxicillin imports, citing market-distorting practices. The company warns Europe risks losing antibiotic manufacturing ca
reuters · 2026-05-28 09:32
Italy's antitrust authority opened an investigation into Biogen over allegations of abusing its dominant position to exclude rival Sandoz from the multiple sclerosis drug market.
reuters · 2026-05-26 23:27
ChemBrief